Prelude Therapeutics's total assets for Q1 2026 were $119.64M, a decrease of -15.34% from the previous quarter. PRLD total liabilities were $59.46M for the fiscal quarter, a -18.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.